Search Results for: toki


Wuhan General Group Updates on Third Scientific Paper Published on Psychedelics

CAPE TOWN, SA / ACCESSWIRE / August 5, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“Wuhan” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the following corporate update:   The research team funded by Wuhan General Group has successfully published a third paper on […]


Willow Biosciences Announces Ground-Breaking Scientific Data for Cannabigerol (CBG) on Human Skin

VANCOUVER, BC, April 20, 2021 /CNW/ – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has completed a series of studies with its development partner, Signum Biosciences, Inc., that demonstrate the safety and anti-inflammatory, anti-aging, and antimicrobial properties of Willow’s cannabigerol (“Willow CBG“). The studies demonstrate that Willow CBG is safe when […]


Mind Cure Engages Dr. Dan Engle as Primary Investigator for Research in Traumatic Brain Injury with Psychedelics

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“Mind Cure”) is pleased to announce the engagement of Dr. Dan Engle as Mind Cure’s Primary Investigator Consultant. Dr. Engle is Board Certified in Psychiatry and Neurology, with a clinical practice that combines functional medicine, integrative psychiatry, neuro-cognitive restoration. He is celebrated for contribution to […]


Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) (“NOVA”) is pleased to announce that it has commenced the diagnostic and treatment phase of its ongoing preclinical model study of autism spectrum disorder (ASD). In this model, which is well accepted by neuroscientists, pregnant rats are exposed to valproic acid (VPA) and the […]


CBD Makes Its Way into Mainstream Retail

The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]


FSD Pharma Announces Phase 2 Clinical Trial IND Filing With The FDA to Treat Patients With COVID-19

– The study is expected to be conducted at 25-30 hospitals in North America – August 31, 2020 02:30 AM Eastern Daylight Time TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has submitted to the U.S. Food and Drug Administration (“FDA”) an Investigational New Drug Application (IND) for […]


FSD Pharma Inc. Announces US$10 Million Registered Direct Offering

TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchase and sale of 2,762,430 Class B Subordinate Voting Shares of the Company (“Shares”) and warrants to purchase 1,381,215 Shares (collectively, the “Securities”) at a purchase price of US$3.62 per […]


Heart Health and COVID-19: Could CBD Offer Some Relief?

It is no secret that people with underlying health conditions are the most vulnerable potential COVID-19 patients. Prominent among these hazardous underlying conditions is heart disease. According to the Centers for Disease Control, patients with heart failure, coronary artery disease, and other heart conditions are particularly at risk for severe illness from the virus. The […]


FSD Pharma Announces US$20M At-The-Market Offering

July 13, 2020 02:30 AM Eastern Daylight Time TORONTO–(BUSINESS WIRE)–FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has entered into an Equity Distribution Agreement dated July 10, 2020 (the “Sales Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”). Under the Sales Agreement the Company may, at its discretion and […]


Revive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 Confirmatory Study for Bucillamine in COVID-19

TORONTO, June 30, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has submitted today its Investigational New Drug (“IND”) application to the U.S. Food and Drug […]


FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA

All subjects completed the trial per protocol, no safety concerns found up to the highest dose tested of 2400 mg/day TORONTO (June 22, 2020) – FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of ultramicronized palmitoylethanolamide (PEA), or FSD201. This single-site study […]


FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

TORONTO, June 3, 2020 /CNW/ – FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA)  to treat COVID-19, the disease caused by the SARS-CoV-2 virus. […]


Naturally Splendid Secures Little Tucker Vegan Treats As Contract Manufacturing Client

Vancouver, British Columbia – TheNewswire – February 11, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce they will begin manufacturing immediately for Little Tucker vegan snacks. Little Tucker products are now sold in approximately 1,500 retailers across Canada including Whole Foods, Sobeys, Circle K, […]


Naturally Splendid’s Natera Sport(TM) Bites Expands 2020 Marketing Program Named Official Snack of the Maple Leaf Junior Golf Tour

Vancouver, British Columbia – TheNewswire – February 4, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to provide details of the 2020 Natera Sport(TM) Bite marketing strategy. Natera Sport(TM) Bites, formulated by Naturally Splendid Advisor and PGA Health Practitioner, Dr. Stuart Love, provides athletes the nutrition […]


NATERA Sport(TM) Bites at Genesis Invitational PGA Tournament

Vancouver, British Columbia – TheNewswire – December 4, 2019 – Naturally Splendid Enterprises Ltd.(“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) a healthy food, hemp product developer and large scale producer for in-house brands as well as global contract manufacturer, is pleased to announce they have been invited to be the feature product at […]


Naturally Splendid Positions for Evolving CBD Market as New Regulations Commence

Vancouver, British Columbia, October 17, 2019 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSX-V:NSP) (OTC:NSPDF), a healthy food, hemp product developer and largescale producer for inhouse brands as well as global contract manufacturer, is pleased to provide our insight in regard to strategic positioning in the evolving cannabinoid extract, edibles […]


Naturally Splendid Positions for Evolving CBD Market as New Regulations Commence

Vancouver, British Columbia – TheNewswire – October 17, 2019 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF), a healthy food, hemp product developer and largescale producer for inhouse brands as well as global contract manufacturer, is pleased to provide our insight in regard to strategic positioning in the evolving cannabinoid extract, edibles markets. Naturally Splendid’s strategy to […]


Naturally Splendid Closes Private Placement

VANCOUVER, British Columbia – TheNewswire – September 6 , 2019 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed the non-brokered private placement financing announced on July 8, 2019, for a total of 6,019,427 units (the “Units”) at $0.14 per Unit, for total gross proceeds of […]


Naturally Splendid Signs Letter of Intent For CBD Toll Processing

Vancouver, British Columbia / TheNewswire / April 24, 2019 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSX-V:NSP) (OTC:NSPDF) is pleased to announce that it has entered into a Letter of Intent with Prairie Pure (1159705 BC LTD) (“Prairie Pure”),wherein Naturally Splendid will provide cannabidiol extraction equipment for a toll processing […]


Naturally Splendid Announces Launch of NATERA™ Sports Bites and Sponsorship Deal With The Professional Golfers Association of BC

(via TheNewswire) March 7, 2019 / TheNewswire / VANCOUVER, BRITISH COLUMBIA – NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSX-V:NSP)(OTCQB: NSPDF)(FRANKFURT:50N) is pleased to announce that response to the recent launch of NATERA™( Sports Bites was well received at the Canadian Health Food Association (CHFA) West trade show that was held over four days […]


HempOmega™ Infused Beer Expands to Iowa; Distribution Agreement Secured

March 5, 2019 / TheNewswire / VANCOUVER, BRITISH COLUMBIA – NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSX-V:NSP)(OTCQB: NSPDF)(FRANKFURT:50N) is pleased to announce that HempOmega(TM) client, Sipp Industries Inc. (“SIPP”), has signed a distribution agreement with Mahaska Bottling Company (“Mahaska”) to distribute Hemp infused IPA, Major Hemp HIPA, throughout the state of Iowa. Sipp’s […]


Naturally Splendid Announces $3,500,000 Non-Brokered Private Placement Facility Upgrades Increases Capacity to Meet Demand

February 27, 2019 / TheNewswire / VANCOUVER, BRITISH COLUMBIA – NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE” (TSX-V:NSP)(OTCQB:NSPDF)(FRANKFURT:50N) is pleased to announce the terms of a private placement for up to $3.5 million comprising of up to 25,000,000 units (each a “Unit”) at a price of $0.14 per Unit (the “Offering”). Each Unit offered […]


Naturally Splendid’s HempOmega™ Infused Beer Expands Distribution to Missouri

February 26, 2019 / TheNewswire / VANCOUVER, BRITISH COLUMBIA – NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSX-V:NSP)(OTCQB: NSPDF)(FRANKFURT:50N) is pleased to announce that Sipp Industries Inc. (“SIPP”) has finalized an agreement with Sparta Distributing for distribution of Major Hemp HIPA in the state of Missouri. Major Hemp H-IPA utilizes Naturally Splendid’s propriety microencapsulated […]


HempOmega™ Beer Continued Growth in the USA

February 21, 2019 / TheNewswire / VANCOUVER, BRITISH COLUMBIA – NATURALLY SPLENDID ENTERPRISES LTD. (“Naturally Splendid” or “NSE”) (TSX-V:NSP)(OTCQB: NSPDF)(FRANKFURT:50N) is pleased to announce that Sipp Industries (“Sipp”) has completed the second run of Major Hemp H-IPA which will be available for immediate distribution upon final bottling and packaging. Major Hemp H-IPA utilizes Naturally Splendid’s […]


Isodiol International Inc. and Supporting Creditors Agree to a Plan of Arrangement for the Divestiture of Kure Corp. and Nullification of up to US$35 million of Required Isodiol Stock Issuances.

VANCOUVER, British Columbia, Jan. 30, 2019 (GLOBE NEWSWIRE) — Isodiol International Inc.(CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) announced today that the Company has obtained conditional voting support from the holders of more than 75% of the former shareholders of Kure Corp. (“Kure”) to give effect to a plan of arrangement (the “Plan”) and […]


Naturally Splendid Closes Private Placement for $638,633.52

VANCOUVER, British Columbia / TheNewswire / Aug. 15, 2018 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSX-V:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce that it has closed a non-brokered private placement financing for a total of 3,547,964 units (the “Units”) at $0.18 per Unit, for total gross proceeds of $638,633.52. Each Unit consisted of one common share of Naturally Splendid and […]


Naturally Splendid Appoints Douglas Mason as Permanent CEO

VANCOUVER, British Columbia / TheNewswire / April 11th, 2018 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSX-V:NSP) (OTCQB:NSPDF) (Frankfurt:50N) announces that further to its January 3rd, 2018 news release, NSE is pleased to announce that after a brief term as interim CEO, NSE has now appointed Mr. Douglas Mason as permanent CEO. Douglas Mason has over 25 years […]


Naturally Splendid Appoints New CFO

VANCOUVER, British Columbia, February 28, 2018 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSX-V:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce that it has appointed Sead Hamzagic as Chief Financial Officer effective immediately , replacing Brian Richardson, who will continue to be a resource for the Company in an advisory board capacity. Mr. Hamzagic has […]


Naturally Splendid Receives $3,536,650 from the Sale of the POS-BPC Facility

VANCOUVER, British Columbia / TheNewswire / February 21, 2018 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSX-V:NSP) (OTCQB:NSPDF) (Frankfurt:50N) is pleased to announce that it has sold its 51% majority interest in the POS BPC Manufacturing Corp. (“BPC”) located in Saskatoon, Saskatchewan, for $3,536,650 CDN. Naturally Splendid purchased its 51% interest in BPC for $1,971,000 in cash and […]


Top 10 Popular Joint Styles to Roll

When the University of Guadalajara‘s very own pharmacist revealed how laborious workers would unwind by smoking a tobacco-marijuana combination, the joint started gaining popularity throughout Mexico and beyond. This was sometime in the 1850’s, although weed aficionados may well have been toking the smoke long before this time! Nevertheless, the pharmacist’s claims exposed the first […]



Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading